Las Condes

12 / 320

576
I direct a critical care pharmacist PGY-2 residency
program and monitor the progress of the resident and
interactions with other preceptors in our health-system.
I participate in multiprofessional journal club discussions,
case conferences and quality review meetings. Like other
professionals I seek to maintain a role in scholarly contri-
butions to the literature and to maintain competency
and be current with the burgeoning literature. As a Board
Certified Critical Care Pharmacist, I have a requirement
for continuing education and maintenance of certifica-
tion, and as a licensed pharmacist I must also maintain
continuing education.
FUTURE
While the clinical pharmacy programs are in various stages
of development globally the need for specialists with a broad
focus on medications and their optimal use is universal. The
American College of Clinical Pharmacists has supported
these training programs and provided education to indi-
viduals and groups. Their publications are used for prepara-
tion and maintenance of board certification by pharmacists
worldwide. This outreach is expected to continue, as more
partners are engaged and more pharmacists and their
multiprofessional teams recognize the opportunities for
clinical pharmacists to improve patient care.
BIBLIOGRAPHIC REFERENCES
1. ,
accessed 3/25/16
2. Viswanathan M, Kahwati LC, Golin CE, et al. Medication
therapy management interventions in outpatient settings. A
systematic review and meta-analysis. JAMA Intern Med 2015;
175: 76-87.
3. Doherty RB, Crowley RA, for the Health and Public Policy
Committee of the American College of Physicians. Principles
supporting dynamic clinical care teams: An American College
of Physicians position paper. Ann Intern Med 2013; 159:
620-626.
4. Executive summary: Collaboration in practice: implementing
team-based care. American College of Obstetricians and
Gynecologists. Obstet Gynecol 2016; 127: 612-617.
5. Proia KK, Thota AB, Gibril JN, et al. Team-based care and
improved blood pressure control. A community guide
systematic review. Am J Prev Med 2014; 47:86-99
6. Joint Commission of Pharmacy Practitioners. Pharmacist
patient care process.
default/files/files/PatientCareProcess.pdf, Accessed 3/25/16
7. h t t p : / / www . a c c p . c om / d o c s / p o s i t i o n s / g u i d e l i n e s /
standardsofpractice.pdf Acccessed 4/18/16
8.
approved-PGY1-Standard-September-2014.pdf, Accessed
3/25/2016
9.
Residency/PGY2-Residencies, Accessed 3/25/16
10. Ruis I, Jiron M, Pinilla E, Paulos C, Pezzani M, Rubio B, et al.
Pharmaceutical care education at the University of Chile. Am J
Pharmaceut Ed 2003; 66:144-147
11. American College of Clinical Pharmacy, McBane SE, Dopp AL,
Abe A, Benavides S, Chester EA, et al. Collaborative drug therapy
The author declares no conflicts of interest in relation to this article.
management and comprehensive medication management-
2015. Pharmacotherapy 2015; 35:e39-e50.
12. Isetts BJ, Brown LM, Schondelmeyer SW, Lenarz LA. Quality
assessment of a collaborative approach for decreasing drug-
related morbidity and achieving therapeutic goals. Arch Intern
Med 2003; 163: 1813-1820
13. 3/25/16
14. Chisholm-Burns MA, Lee JK, Spivey CA, Slack M, Herrier RN,
Hall-Lipsy E, et al. US pharmacists’ effect as team members on
patient care. Med Care 2010; 10:923-933.
15. Murray MD, Ritchey ME, Wu J, Tu W. Effect of a pharmacist on
adverse drug events and medication errors in outpatients with
cardiovascular disease. Arch Intern Med 2009; 169:757-763.
16. Koshman SL, Charrois TL, Simpson SH, McAlister FA, Tsuyuki RT.
Pharmacist care of patients with heart failure. Arch Intern Med
2008; 168:687-64.
17. Dunn SP, Birtcher KK, Beavers CJ, Baker WL, Brouse SD, Page
RL, et al. The role of the clinical pharmacist in the care of
patients with cardiovascular disease. J Am Coll Cardiol 2015;
66:2129-2139.
18. Brandis R, Rodgers GP, Handberg EM. President’s page: team-
based care: a solution for our health care delivery challenges. J
Am Coll Cardiol 2011; 57:1123-1125.
19. Kucukarslan SN, Peters M, Mlynarek M, Nafziger DA.
Pharmacists on rounding teams reduce preventable adverse
drug events in hospital general medicine units. Arch Intern
Med 2003; 163:2014-2018.
20. Kopp BJ, Mrsan M, Erstad BL, Duby JJ. Cost implications of and
potential adverse events prevented by intervention of a critical
care pharmacist. Am J Health-Syst Pharm 2007; 64:2483-
2487.
21. Kaboli PJ, Hoth AB, McClimon BJ, Schnipper JL. Clinical
[REV. MED. CLIN. CONDES - 2016; 27(5) 571-577]